CPT 87534: HIV-1 Detection by Direct Probe Technique

CPT code 87534 designates a laboratory molecular diagnostic assay for human immunodeficiency virus type 1 (HIV‑1) performed with a direct probe technique. This code captures a targeted nucleic acid detection method used to identify HIV‑1 in clinical specimens and supports diagnosis, infection confirmation, and patient management decisions. Nationally, accurate coding for HIV diagnostic tests is important for surveillance, public health reporting, and appropriate laboratory reimbursement.

Key payers considered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical purpose of the test, typical sites of service, and the billing context for laboratory molecular diagnostics. The publication outlines benchmarks and payer coverage considerations, summarizes clinical relevance for HIV‑1 detection, and highlights where policy updates or coding clarifications can affect lab billing and claims processing.

The content is intended for a national audience of billing professionals, laboratory administrators, and health policy analysts seeking a clear description of the code, its clinical role, and implications for payer interactions and claims administration. Data not available in the input will be noted where applicable.

Billing Code Overview

CPT code 87534 describes a laboratory test performed by a lab analyst that detects human immunodeficiency virus type 1 (HIV‑1) using a direct probe technique. The service is a molecular diagnostic test designed to identify the presence of HIV‑1 genetic material in patient specimens.

Service Type: Laboratory — molecular diagnostic (direct probe assay)

Typical Site of Service: Clinical laboratory or hospital laboratory (inpatient or outpatient collection sites)

Data not available in the input.

Clinical Context

A 32-year-old adult presents to an outpatient infectious disease clinic for evaluation after a recent occupational exposure to blood. The clinician documents an exposure event and orders laboratory testing for HIV-1 using a direct probe nucleic acid hybridization assay. The patient is registered at the clinical laboratory; a phlebotomy specimen is collected and sent to the molecular diagnostics lab. The lab analyst performs 87534 to detect HIV-1 RNA/DNA sequences by direct probe technique. Results are reported to the ordering provider and incorporated into the patient’s electronic medical record. Follow-up counseling and additional testing (antibody/antigen immunoassay or RNA PCR) are scheduled as indicated by the result.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting only the professional (interpretation) component if the lab separates technical and professional components and the professional portion is billed separately.
`TC`	Technical component	Use when reporting only the technical component (laboratory processing, reagents, instrumentation) and the facility bills separately from the professional component.

Taxonomy Code	Specialty	Notes
`0000A`	Clinical Laboratory Scientist/Technologist	Performs molecular and direct probe testing in the laboratory setting.
`0000B`	Infectious Disease Specialist	Orders and interprets HIV diagnostic testing and manages follow-up.
`0000C`	Pathology/Clinical Pathology	Oversees laboratory quality, test validation, and reporting.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z20.2`	Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission	Indicates an exposure event prompting HIV testing with `87534`.
`Z11.4`	Encounter for screening for human immunodeficiency virus (HIV)	Routine screening indication for HIV testing, appropriate for ordering `87534` in some contexts.
`R75`	Inconclusive laboratory evidence of human immunodeficiency virus [HIV]	Applied when initial assays are indeterminate and further testing with direct probe methods is performed.
`B20`	Human immunodeficiency virus [HIV] disease	Diagnosis for confirmed HIV infection; direct probe testing may be part of diagnostic or monitoring workup.
`Z71.7`	Human immunodeficiency virus (HIV) counseling	Counseling encounter associated with HIV diagnostic testing workflows.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87534`	The lab analyst performs a test for HIV1 using direct probe technique.	Primary code representing the direct probe HIV-1 molecular assay; used when the lab performs this specific test.
`87389`	Infectious agent antibody detection by enzyme immunoassay technique (EIA)	Often performed before or after direct probe assays as initial HIV screening by antibody/antigen methods.
`87536`	HIV-1/2 differentiation assay	Performed when initial testing indicates HIV positivity to distinguish HIV-1 from HIV-2.
`87535`	HIV-1, direct probe technique (alternative specimen or method)	Related molecular techniques that may be used in confirmatory workflows.
`87435`	Infectious agent detection by nucleic acid (e.g., NAAT), amplified probe technique	Performed in molecular confirmation or viral load contexts alongside direct probe testing.

OpenPayer

Summary & Overview